1 | technical storage or access | | | | | | | 5 | 0.97% |
2 | read more launch of | | | | | | | 3 | 0.58% |
3 | storage or access is | | | | | | | 3 | 0.58% |
4 | over 80 countries 3 | | | | | | | 2 | 0.39% |
5 | own leading brands rid | | | | | | | 2 | 0.39% |
6 | of our products 5 | | | | | | | 2 | 0.39% |
7 | production of our products | | | | | | | 2 | 0.39% |
8 | the production of our | | | | | | | 2 | 0.39% |
9 | the health and wellbeing | | | | | | | 2 | 0.39% |
10 | health and wellbeing of | | | | | | | 2 | 0.39% |
11 | and wellbeing of consumers | | | | | | | 2 | 0.39% |
12 | for the production of | | | | | | | 2 | 0.39% |
13 | elimax pistal ultractive 4 | | | | | | | 2 | 0.39% |
14 | brands best in class | | | | | | | 2 | 0.39% |
15 | 1 wart cryo treatment | | | | | | | 2 | 0.39% |
16 | innovations that are marketed | | | | | | | 2 | 0.39% |
17 | their brands best in | | | | | | | 2 | 0.39% |
18 | under their brands best | | | | | | | 2 | 0.39% |
19 | innovations under their brands | | | | | | | 2 | 0.39% |
20 | products 1 wart cryo | | | | | | | 2 | 0.39% |
21 | storage or access that | | | | | | | 2 | 0.39% |
22 | or access that is | | | | | | | 2 | 0.39% |
23 | access that is used | | | | | | | 2 | 0.39% |
24 | that is used exclusively | | | | | | | 2 | 0.39% |
25 | is used exclusively for | | | | | | | 2 | 0.39% |
26 | consumer healthcare companies that | | | | | | | 2 | 0.39% |
27 | presence in over 80 | | | | | | | 2 | 0.39% |
28 | in over 80 countries | | | | | | | 2 | 0.39% |
29 | the subscriber or user | | | | | | | 2 | 0.39% |
30 | development of winning product | | | | | | | 2 | 0.39% |
31 | by science committed to | | | | | | | 2 | 0.39% |
32 | by nature driven by | | | | | | | 2 | 0.39% |
33 | facts oystershell highlights 1 | | | | | | | 2 | 0.39% |
34 | inspired by nature driven | | | | | | | 2 | 0.39% |
35 | key facts oystershell highlights | | | | | | | 2 | 0.39% |
36 | the technical storage or | | | | | | | 2 | 0.39% |
37 | nature driven by science | | | | | | | 2 | 0.39% |
38 | in development of winning | | | | | | | 2 | 0.39% |
39 | of winning product innovations | | | | | | | 2 | 0.39% |
40 | treatment leading innovator in | | | | | | | 2 | 0.39% |